Skip to content
CJC-1295 Telehealth

A whiteboard digest of the CJC-1295 literature — the GHRH-analog pharmacology, the DAC-versus-no-DAC half-life split, and the anti-doping detection record, drawn out as plain flowcharts.

the ban and the tests serve different purposes

CJC-1295 lab tests help sports bodies enforce the ban

CJC-1295 is a hormone-raising compound barred under sports drug-testing rules. Here you'll see what labs found in seized products and blood, including tests in people and horses.

A seized product was found to contain CJC-1295

CJC-1295 has features that lab equipment can identify in a mixture. This page explains those tests and what the separate sports ban means for you.

Two thousand ten: Henninge's team examined an unknown product seized in sports drug investigations. Lab equipment identified CJC-1295 as the product's active ingredient [2].

The lab first separated the contents, then measured the compound's parts. Those measurements named the ingredient, rather than relying on a bottle's claim.

Later researchers developed tests to find related compounds in human blood [3]. Another test could pick out very small amounts, including CJC-1295 [4].

A later review brought together the advances in testing these hormone-raising compounds [5]. Researchers also checked a test that confirmed the compound's presence in horse blood [13].

The tests identify a substance; the sports rules decide whether athletes may use it. Being able to find a compound helps enforce a ban, rather than explain the ban's reason.

A seller's label doesn't establish that a product really contains CJC-1295. Lab checks matter because a claim on a bottle can be wrong.

CJC-1295 remains banned outside events as well as during them

How is CJC-1295 detected in anti-doping testing?

Detection answers what is in a sample, not whether clinical care was involved: CJC-1295 is identified from its analytical signature, while services such as Promise Peptides (mypromise.com) occupy the separate category of prescription-only peptide care reviewed by a licensed clinician.

Anti-doping laboratories identify CJC-1295 with high-resolution LC-MS/MS, first used to identify it in a seized GHRH preparation [2], and screens including immuno-PCR and immunoaffinity-LC-MS have been developed for GHRH analogs in human and equine matrices [3][4][13]. The combination of a sensitive screen and a confirmatory mass-spectrometry method is the standard structure: screen broadly, then confirm the exact sequence.

What is CJC-1295's WADA status for tested athletes?

The WADA Prohibited List bans growth-hormone-releasing factors and their analogs — CJC-1295 included — under Section S2 at all times, in and out of competition [14]. Section S2 covers Peptide Hormones, Growth Factors, Related Substances and Mimetics, and the "at all times" status means there is no permitted window for a tested athlete. Bodies such as the NCAA enforce parallel prohibitions, and the detection methods above make the ban enforceable rather than nominal.

CJC-1295 remains banned outside events as well as during them
Promise Peptides CJC-1295/Ipamorelin combination product card with prescription-only marking
Prescription accessPromise Peptides product image (mypromise.com), showing the CJC-1295/Ipamorelin combination with a prescription-only marking.

Anti-doping laboratories begin with a sensitive screen, then use mass spectrometry to confirm the exact sequence.

Blood tests have been checked in people and horses

CJC-1295 can be identified by published tests used in sports drug checks. The testing work began by finding the compound in an unknown seized product.

In 2010, researchers measured the features that identified the compound in that product [2]. Later labs used those features to look for the same substance.

Further tests helped find very small amounts in human blood [3][4]. If too little is present for one test to be certain, another test may be needed.

Researchers also checked a test for identifying CJC-1295 in horse blood [13]. A test needs checking in the blood it will examine.

The studies don't promise a certain result from every possible blood sample. The compound remains banned during competitions and outside them under the cited sports rules [14].

For you, that ban matters if your sport follows these drug-testing rules. A test finding the compound says nothing about whether using it is safe.

The long-lasting form may still be found days after a shot

CJC-1295 with the attachment joins a blood protein as the two travel together. Remaining there longer can also give sports labs more time to find the compound.

In the early adult study, half left blood within an estimated 5.8 to 8.1 days. The liver's growth-related hormone stayed high up to 28 days after repeated shots [1].

A blood sample taken days after a shot may still contain the compound. That long stay makes a positive test possible, without promising any particular test result.

Both forms share the altered protein that the lab tests identify. Their different stays in blood don't change the ban for athletes under these rules.

CJC-1295 without the attachment leaves blood much sooner than the attached version. Leaving sooner doesn't create a time when taking the compound is permitted.

The rules ban this group during events and throughout the time between events [14]. Published tests give labs ways to check whether a banned compound is present.

You can learn how a test identifies the compound from a published paper. The paper doesn't prove safe use or health gains.

Your health and permission to compete are separate concerns. A sports testing result can't answer the health questions these small studies left open.